FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Evofem Biosciences (NASDAQ: EVFM) reported Q4 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29).
"The Evofem team's exceptional execution in 2019 laid the groundwork for what will be a transformative year for the Company," said Saundra Pelletier, Chief Executive Officer, Evofem Biosciences. "We are... More

